MedPath

Investigation of the effects of anaesthetic choice on ventilation-perfusion scatter and lung gas exchange.

Phase 4
Conditions
Impaired lung function under anaesthesia
Anaesthesiology - Anaesthetics
Respiratory - Normal development and function of the respiratory system
Registration Number
ACTRN12614000226606
Lead Sponsor
Austin Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Patients undergoing general anaesthesia for surgery requiring relacant GA with an arterial line for cardiovascular monitoring.

Exclusion Criteria

Severe impairment of lung function. (FEV1 or FVC less than 30% predicted), or morbid obesity (Body mass index (BMI) greater than 40 kg/m2)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in ventilation-perfusion scatter in the lung indexed by the log standard deviation of the distribution of ventilation and blood flow (d log SD) measured using the Multiple Inert Gas Elimination Technique (MIGET).[d log SD between measurement made pre-induction of anaesthesia to 2 hours after induction.]
Secondary Outcome Measures
NameTimeMethod
Blood gas indices of ventilation-perfusion (V/Q) scatter: PaO2, P(A-a)O2, P(A-a)CO2, shunt fraction and deadspace fraction.[Change from measurement made pre-induction of anaesthesia to 2 hours after induction.]
© Copyright 2025. All Rights Reserved by MedPath